Anemia and Kidney Disease
Anemia and Kidney Disease
Part of NephTimes
Advertisement
Charlotte RobinsonAnemia and Kidney Disease | November 5, 2024
Individualized dosing of ESAs using anemia therapy assistance software improved hemoglobin stability and ESA utilization.
Read More
Charlotte RobinsonAnemia and Kidney Disease | November 5, 2024
Researchers examined the long-term safety of oral hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia of CKD.
Charlotte RobinsonAnemia and Kidney Disease | October 10, 2024
Under a new agreement with Akebia, US Renal Care will be able to prescribe Vafseo to dialysis patients with anemia of CKD.
Charlotte RobinsonAnemia and Kidney Disease | September 20, 2024
Anemia of CKD in China and its related health care costs are projected to rise, but earlier screening and treatment can help.
Charlotte RobinsonAnemia and Kidney Disease | September 19, 2024
A recent study compared anemia diagnosis and treatment in older patients hospitalized in nephrology versus geriatric units.
Charlotte RobinsonAnemia and Kidney Disease | September 12, 2024
How does early vs delayed treatment with long-acting ESAs affect renal and cardiovascular outcomes in patients with NDD-CKD?
Charlotte RobinsonAnemia and Kidney Disease | September 12, 2024
Researchers used KPIs to evaluate anemia and iron status management in children on hemodialysis.
Charlotte RobinsonAnemia and Kidney Disease | August 26, 2024
A study examined the prevalence of iron deficiency and associated factors in patients with stage 4-5 CKD.
Charlotte RobinsonAnemia and Kidney Disease | August 26, 2024
A study examined the effect of an egg white diet in relation to anemia in patients with end-stage renal disease on dialysis.
Charlotte RobinsonAnemia and Kidney Disease | July 15, 2024
Akebia Therapeutics has ended its license agreement with CSL Vifor for Vafseo and announced WAC pricing for the anemia drug.
Charlotte RobinsonAnemia and Kidney Disease | June 27, 2024
A study examined the effect of C-reactive protein on the efficacy of HIF-PHIs for anemia with CKD.
Charlotte RobinsonAnemia and Kidney Disease | June 26, 2024
Kidney transplant recipients may be at a higher risk of developing parvovirus B19-related complications.
Charlotte RobinsonAnemia and Kidney Disease | June 25, 2024
Iron replacement with ferric citrate hydrate decreased cFGF23 and normalized platelet count with anemia regardless of CKD.
Charlotte RobinsonAnemia and Kidney Disease | May 21, 2024
Anemia and iron metabolism disorders can affect the evaluation process for kidney transplantation.
Charlotte RobinsonAnemia and Kidney Disease | April 26, 2024
Researchers examined the roles of hyperuricemia and anemia in all-cause mortality with chronic kidney disease (CKD).
Charlotte RobinsonAnemia and Kidney Disease | April 25, 2024
The ERA reviewed phase 3 trials to clarify the mechanism behind HIF-PHi and their role in managing CKD-related anemia.
Charlotte RobinsonAnemia and Kidney Disease | June 3, 2024
The FDA approved Vafseo (vadadustat) to treat anemia due to chronic kidney disease (CKD) in adults on dialysis.
Charlotte RobinsonAnemia and Kidney Disease | March 22, 2024
SGLT2 inhibitors have benefits for anemia risk but their effectiveness among patients with T2D and CKD stage 1-3 was unclear.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
Patients with early chronic kidney disease (CKD) frequently develop anemia.
Victoria SochaAnemia and Kidney Disease | February 5, 2024
In multivariate logistic regression analysis, a higher UFR was associated with lower hemoglobin levels.
Advertisement
Advertisement
Advertisement
Latest News

December 11, 2024